08/19/2024
3:15 PM | Beam Therapeutics (Issuer)
Cavanagh Bethany J (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
08/06/2024
6:08 AM | Beam Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/15/2024
6:01 AM | Beam Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/27/2024
3:14 PM | Beam Therapeutics (Subject)
Evans John M. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/10/2024
3:30 PM | Beam Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/07/2024
3:42 PM | Beam Therapeutics (Issuer)
Fishman Mark (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/07/2024
3:42 PM | Beam Therapeutics (Issuer)
Walsh Kathleen E (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
|
06/07/2024
3:45 PM | Beam Therapeutics (Issuer)
COOPER GRAHAM K (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/07/2024
3:47 PM | Beam Therapeutics (Issuer)
Ho Carole (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/07/2024
3:47 PM | Beam Therapeutics (Issuer)
MARAGANORE JOHN (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/07/2024
3:48 PM | Beam Therapeutics (Issuer)
Shaw Christi (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/07/2024
6:09 AM | Beam Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/07/2024
6:19 AM | Beam Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
04/19/2024
3:25 PM | Beam Therapeutics (Filer)
| Form ARS | |
04/19/2024
3:15 PM | Beam Therapeutics (Filer)
| Form DEF 14A | |
04/19/2024
3:20 PM | Beam Therapeutics (Filer)
| Form DEFA14A | |
04/04/2024
7:56 PM | Beam Therapeutics (Subject)
Ciaramella Giuseppe (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
04/04/2024
7:57 PM | Beam Therapeutics (Subject)
Burrell Terry-Ann (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
04/04/2024
7:57 PM | Beam Therapeutics (Subject)
Evans John M. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
04/04/2024
7:55 PM | Beam Therapeutics (Subject)
Simon Amy (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
04/04/2024
7:56 PM | Beam Therapeutics (Subject)
Bellon Christine (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
04/03/2024
6:39 PM | Beam Therapeutics (Issuer)
Burrell Terry-Ann (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/03/2024
6:40 PM | Beam Therapeutics (Issuer)
Bellon Christine (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/03/2024
6:43 PM | Beam Therapeutics (Issuer)
Simon Amy (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/03/2024
6:33 PM | Beam Therapeutics (Issuer)
Ciaramella Giuseppe (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/03/2024
6:36 PM | Beam Therapeutics (Issuer)
Evans John M. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/02/2024
3:22 PM | Beam Therapeutics (Subject)
Simon Amy (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
04/02/2024
3:10 PM | Beam Therapeutics (Issuer)
Simon Amy (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/02/2024
3:10 PM | Beam Therapeutics (Issuer)
Burrell Terry-Ann (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/28/2024
5:13 PM | Beam Therapeutics (Subject)
Evans John M. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/27/2024
6:40 AM | Beam Therapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
02/27/2024
6:22 AM | Beam Therapeutics (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
02/27/2024
5:43 AM | Beam Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/15/2024
1:34 PM | Beam Therapeutics (Issuer)
FMR LLC (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/14/2024
2:18 PM | ARCH Venture Fund IX, L.P. (Filed by)
Beam Therapeutics (Subject)
| Form SC 13G/A | |
02/12/2024
2:38 PM | Beam Therapeutics (Subject)
Farallon Capital Partners, L.P. (Filed by)
| Form SC 13G/A | |
02/09/2024
7:35 AM | Beam Therapeutics (Subject)
FMR LLC (Filed by)
| Form SC 13G/A | |
02/06/2024
6:27 AM | Beam Therapeutics (Subject)
Temasek Holdings Ltd (0001021944) (Filed by)
| Form SC 13G/A | |
01/31/2024
3:47 PM | Beam Therapeutics (Subject)
Evans John M. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/29/2024
3:00 PM | ARK Investment Management LLC (Filed by)
Beam Therapeutics (Subject)
| Form SC 13G/A | |
01/25/2024
3:59 PM | Beam Therapeutics (Subject)
BlackRock Inc. (Filed by)
| Form SC 13G/A | |
Trump’s “Tax Free” Retirement Strategy (Ad) Since 1924 — over one hundred years — the US dollar has lost nearly 18x its value.
If you're planning on retiring any time soon...
Every retirement dollar you have invested in paper assets will only continue to drop in value.
We just released a Free Guide that reveals all the details. Click here to get the free Gold Guide now. |
01/24/2024
7:42 AM | Beam Therapeutics (Subject)
STATE STREET CORP (Filed by)
| Form SC 13G | |
01/08/2024
5:55 AM | Beam Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/05/2024
3:30 PM | Beam Therapeutics (Issuer)
Bellon Christine (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/27/2023
9:56 AM | Beam Therapeutics (Issuer)
FMR LLC (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/14/2023
3:10 PM | Beam Therapeutics (Issuer)
Shaw Christi (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
12/14/2023
3:15 PM | Beam Therapeutics (Issuer)
Shaw Christi (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/20/2023
3:20 PM | Beam Therapeutics (Subject)
Bellon Christine (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/08/2023
6:30 AM | Beam Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/08/2023
6:00 AM | Beam Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/01/2023
3:30 PM | Beam Therapeutics (Issuer)
Simon Amy (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/31/2023
5:44 AM | Beam Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/30/2023
3:41 PM | Beam Therapeutics (Subject)
Simon Amy (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/19/2023
7:50 AM | Beam Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/04/2023
3:30 PM | Beam Therapeutics (Issuer)
Bellon Christine (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/22/2023
2:20 PM | Beam Therapeutics (Subject)
Farallon Capital Partners, L.P. (Filed by)
| Form SC 13G | |
